Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Options, Sold Out, 2017 Q1, Page 5

CITADEL ADVISORS LLC historic quarter change: USA Options, Sold out

In put and call options, at their filed underlying value (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 48,961 positions, added to 115,287, reduced 112,564 and sold out of 46,247.

  • Q1 2017: Stock ARALEZ PHARMACEUTICALS INC; Country of operation —; Class Cmn · Call; Shares before 10,700.
  • Q1 2017: Stock FORM HLDGS CORP; Country of operation —; Class Cmn · Put; Shares before 21,900.
  • Q1 2017: Stock SECOND SIGHT MED PRODS INC; Country of operation —; Class Cmn · Call; Shares before 21,300.
  • Q1 2017: Stock FORM HLDGS CORP; Country of operation —; Class Cmn · Call; Shares before 19,700.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q1 2017ARALEZ PHARMACEUTICALS INC
CUSIP 03852X100
—Cmn · Call10,7000-10,700$47$0-$472017-05-12
Q1 2017FORM HLDGS CORP
CUSIP 34634E102
—Cmn · Put21,9000-21,900$47$0-$472017-05-12
Q1 2017SECOND SIGHT MED PRODS INC
CUSIP 81362J100
—Cmn · Call21,3000-21,300$42$0-$422017-05-12
Q1 2017FORM HLDGS CORP
CUSIP 34634E102
—Cmn · Call19,7000-19,700$42$0-$422017-05-12
Q1 2017NDLS
NOODLES & CO
United StatesCmn · Call10,0000-10,000$41$0-$412017-05-12
Q1 2017CHINA FIN ONLINE CO LTD
CUSIP 169379104
—Cmn · Put11,0000-11,000$40$0-$402017-05-12
Q1 2017NAVIOS MARITIME PARTNERS L P
CUSIP Y62267102
—Cmn · Call27,2000-27,200$38$0-$382017-05-12
Q1 2017PARKERVISION INC
CUSIP 701354300
—Cmn · Put19,8000-19,800$36$0-$362017-05-12
Q1 2017ODYSSEY MARINE EXPLORATION I
CUSIP 676118201
United StatesCmn · Put10,5000-10,500$36$0-$362017-05-12
Q1 2017CLEARSIGN COMBUSTION CORP
CUSIP 185064102
—Cmn · Call10,3000-10,300$35$0-$352017-05-12
Q1 2017TANDEM DIABETES CARE INC
CUSIP 875372104
—Cmn · Put15,6000-15,600$34$0-$342017-05-12
Q1 2017UTI
UNIVERSAL TECHNICAL INST INC
United StatesCmn · Call11,4000-11,400$33$0-$332017-05-12
Q1 2017NORTH ATLANTIC DRILLING LTD
CUSIP G6613P129
—Cmn · Put10,0000-10,000$32$0-$322017-05-12
Q1 2017IDERA PHARMACEUTICALS INC
CUSIP 45168K306
—Cmn · Call20,9000-20,900$31$0-$312017-05-12
Q1 2017RIGEL PHARMACEUTICALS INC
CUSIP 766559603
—Cmn · Put13,2000-13,200$31$0-$312017-05-12
Q1 2017BIODELIVERY SCIENCES INTL IN
CUSIP 09060J106
—Cmn · Put17,4000-17,400$30$0-$302017-05-12
Q1 2017ALCOBRA LTD
CUSIP M2239P109
—Cmn · Put14,5000-14,500$30$0-$302017-05-12
Q1 2017NORTHERN OIL & GAS INC NEV
CUSIP 665531109
—Cmn · Put10,4000-10,400$29$0-$292017-05-12
Q1 201722ND CENTY GROUP INC
CUSIP 90137F103
—Cmn · Put25,4000-25,400$28$0-$282017-05-12
Q1 2017NAVIOS MARITIME HOLDINGS INC
CUSIP Y62196103
—Cmn · Call20,0000-20,000$28$0-$282017-05-12
Q1 2017ALCOBRA LTD
CUSIP M2239P109
—Cmn · Call13,1000-13,100$28$0-$282017-05-12
Q1 2017EV ENERGY PARTNERS LP
CUSIP 26926V107
—Cmn · Put12,8000-12,800$27$0-$272017-05-12
Q1 2017GULFMARK OFFSHORE INC
CUSIP 402629208
—Cmn · Put15,2000-15,200$27$0-$272017-05-12
Q1 2017VANGUARD NAT RES LLC
CUSIP 92205F106
—Cmn · Call37,9000-37,900$26$0-$262017-05-12
Q1 2017CHESAPEAKE GRANITE WASH TR
CUSIP 165185109
—Cmn · Put10,9000-10,900$25$0-$252017-05-12
Q1 2017OVASCIENCE INC
CUSIP 69014Q101
—Cmn · Put15,3000-15,300$23$0-$232017-05-12
Q1 2017EXCO RESOURCES INC
CUSIP 269279402
—Cmn · Put26,3000-26,300$23$0-$232017-05-12
Q1 2017INFINITY PHARMACEUTICALS INC
CUSIP 45665G303
—Cmn · Put16,3000-16,300$22$0-$222017-05-12
Q1 2017SENOMYX INC
CUSIP 81724Q107
—Cmn · Put21,6000-21,600$21$0-$212017-05-12
Q1 2017PSIVIDA CORP
CUSIP 74440J101
—Cmn · Put12,0000-12,000$21$0-$212017-05-12
Q1 2017EVINE LIVE INC
CUSIP 300487105
—Cmn · Call13,8000-13,800$21$0-$212017-05-12
Q1 2017ARWR
ARROWHEAD PHARMACEUTICALS IN
United StatesCmn · Put13,7000-13,700$21$0-$212017-05-12
Q1 2017SPHERE 3D CORP NEW
CUSIP 84841L100
—Cmn · Call67,4000-67,400$20$0-$202017-05-12
Q1 2017PRIMERO MNG CORP
CUSIP 74164W106
—Cmn · Put25,5000-25,500$20$0-$202017-05-12
Q1 2017HARRIS & HARRIS GROUP INC
CUSIP 413833104
—Cmn · Call14,4000-14,400$20$0-$202017-05-12
Q1 2017CORMEDIX INC
CUSIP 21900C100
—Cmn · Call10,6000-10,600$16$0-$162017-05-12
Q1 2017CORMEDIX INC
CUSIP 21900C100
—Cmn · Put10,0000-10,000$15$0-$152017-05-12
Q1 2017TGB
TASEKO MINES LTD
CanadaCmn · Call10,9000-10,900$9$0-$92017-05-12
Q1 2017GOLDEN STAR RES LTD CDA
CUSIP 38119T104
—Cmn · Put10,4000-10,400$8$0-$82017-05-12
Q1 2017AVEO PHARMACEUTICALS INC
CUSIP 053588109
—Cmn · Call10,7000-10,700$6$0-$62017-05-12
Q1 2017GEVO INC
CUSIP 374396208
—Cmn · Call10,2000-10,200$2$0-$22017-05-12
Q1 2017MEMORIAL PRODTN PARTNERS LP
CUSIP 586048100
—Cmn · Call11,0000-11,000$1$0-$12017-05-12

Similar Firms

Firm NameCountry13F ValueHoldings
Capital Research Global InvestorsUnited States$644.560B459
Invesco Ltd.United States$653.294B23,552
CHARLES SCHWAB INVESTMENT MANAGEMENT INCUnited States$654.473B3,645
UBS Group AGSwitzerland$666.317B22,771
ROYAL BANK OF CANADACanada$570.144B25,608
Bank of New York Mellon CorpUnited States$543.906B33,728
WELLINGTON MANAGEMENT GROUP LLPUnited States$535.463B7,458
WELLS FARGO & COMPANY/MNUnited States$530.336B17,971
Capital World InvestorsUnited States$732.940B620
DIMENSIONAL FUND ADVISORS LPUnited States$481.393B13,635